Orphan Drugs Industry Advisory & Intelligence
Skip to content
  • Home
  • About us
  • ODI Advisory
  • Press, Articles & News
  • References

Category Archives: Pulse

Big (bio)pharma involvement and orphan diseases: reality or “orphan-washing”? Part 2 – The Pfizer case

Posted on May 2, 2016 by christian@orphandrugsindustry.com

Link to article

Posted in Pulse | Tagged Big pharma, Orphan drugs, Rare diseases

Big (bio)pharma involvement and orphan diseases: reality or “orphan-washing”? Part 1 – The Novartis case

Posted on April 26, 2016 by christian@orphandrugsindustry.com

Link to article

Posted in Pulse | Tagged Big pharma, Orphan drugs, Rare diseases
  • Archives

    • May 2019
    • May 2016
    • April 2016
  • Meta

    • Register
    • Log in
  • Click to contact us
  • Visitors

    • 3,835 hits
  • Headquarter

    1, rue Roch ar Ruguel
    29680 Roscoff, France
    Tel: +33 (0)6 67 26 60 92
Orphan Drugs Industry Advisory & Intelligence
Create a website or blog at WordPress.com
  • Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
    To find out more, including how to control cookies, see here: Our Cookie Policy